companydata.dkcompanydata.dk

Idun Biologics ApS: Financial statements 2025

CVR: 43750380

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Idun Biologics ApS (CVR 43750380) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. That is a decrease of 8% compared with the year before. Equity in the 2025 report amounted to DKK -239,341. The company had 1 employee in the financial year.

Gross Profit
DKK 475,329
Profit/Loss
DKK -85,011
Equity
DKK -239,341
Total Assets
DKK 1,255,753
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-475K-85K-239K1
2024-517K-192K-154K2
2023-662K-2K38K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Idun Biologics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Idun Biologics ApS: The 2024 annual report is outJul 8, 2025

Idun Biologics ApS has published its annual report for 2024. Gross profit came to DKK 516,626, and the net result was DKK -192,043.

About Idun Biologics ApS

Idun Biologics ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Clarisse Eve Chiche-Lapierre and Jens Frederik Teilfeldt Hansen. The company is owned by Ymir Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. Equity in the 2025 report amounted to DKK -239,341.

Source: annual report 2025, Danish Business Authority

Other financial years